2024 PROSTATE CANCER
PATIENTS & CAREGIVERS CONFERENCE
SATURDAY, SEPTEMBER 7TH & SUNDAY, SEPTEMBER 8TH, 2024
WESTIN LAX | LOS ANGELES, CA
LEARN ABOUT PROSTATE CANCER TREATMENTS, SIDE EFFECTS, AND LIFESTYLE.
Get face to face with prostate cancer experts in every field. Hosted in Los Angeles, California, the PCRI conference is a full-featured educational experience for prostate cancer patients and caregivers.
Each day consists of straightforward presentations, extended Q+A sessions, individualized small-group sessions, and a variety of fun and enriching activities to facilitate camaraderie. You can expect to gain comprehensive knowledge of your disease and become empowered to make the best decisions.
DEDICATED TO TOM KIRK
The upcoming conference is dedicated to the memory of Thomas Kirk, a devoted leader in the fight against prostate cancer.
Tom's remarkable legacy, spanning his work with prostate cancer non-profits, Us TOO International and the National Alliance of State Prostate Cancer Coalitions, continues to inspire and guide our efforts today.
Join us for the 2024 Prostate Cancer Patients & Caregivers Conference, hosted by the Prostate Cancer Research Institute (PCRI), at The Westin Los Angeles Airport. This highly anticipated event will provide a wealth of knowledge, support, and resources tailored specifically for prostate cancer patients and their caregivers.
Take advantage of our special accommodation rate of $185 per night, inclusive of taxes and service fees, by booking your room through our dedicated link.
Seating for this conference is limited, so it's important to register and reserve your room as soon as possible!
Hosted at The Westin Los Angeles Airport!
Meet Our Speakers
Elizabeth Heath, MD - Advanced Treatments & Side Effects
Dr. Heath is the Associate Center Director of Translational Sciences, leads the Genitourinary Oncology Multidisciplinary Team at the Karmanos Cancer Institute and is a professor of Oncology at Wayne State University School of Medicine. She leads groundbreaking research in prostate cancer, with a focus on addressing health disparities in clinical trials. A respected leader in her field, Dr. Heath has received numerous awards and serves on several national committees dedicated to cancer research. Read More
Mack Roach III, MD - Radiation Treatments and Side Effects
Dr. Roach is a Professor of Radiation Oncology and Urology at the University of California, San Francisco, and is widely recognized as a leading authority on localized prostate cancer treatment. His research focuses on the use of advanced radiation therapies, such as image-guided IMRT and Brachytherapy, to optimize treatment outcomes while minimizing side effects. Dr. Roach has published over 200 peer-reviewed articles and was appointed by President Obama to the National Cancer Advisory Board. Read More
Daniel Margolis, MD - Prostate Imaging
Dr. Margolis is a Professor of Radiology specializing in Abdominal Imaging and leads clinical efforts in using prostate MRI for cancer detection, treatment planning, and follow-up, contributing to numerous publications demonstrating its effectiveness. Dr. Margolis is a member of the American College of Radiology’s Prostate Imaging Reporting and Data Systems steering committee and has lectured at prestigious conferences worldwide. Fluent in Spanish and Swedish, Dr. Margolis has authored more than 100 publications. Read More
Laurence Klotz, MD - Active Surveillance
Dr. Laurence Klotz is a Professor of Surgery at the University of Toronto and holds the Sunnybrook Chair of Prostate Cancer Research. He is the Founder and Chairman of the Canadian Urology Research Consortium and the Chair of the Global GU Oncology Group. With over 350 publications and several books, Dr. Klotz is a widely respected uro-oncologist whose main research focus is prostate cancer. He has served on numerous medical boards and editorial committees, and his contributions to the field have earned him many prestigious awards. Read More
Jeffrey Brady, MD - ED & Post Treatment Repair
Dr. Jeff D. Brady, MD, FACS, is a board-certified urologist with over 20 years of experience, specializing in reconstructive urology since 2021. Known for his advanced training and expertise, Dr. Brady is a trusted resource for managing complex urologic conditions in both adults and children. His practice offers both surgical and nonsurgical treatments for issues such as erectile dysfunction, male urinary incontinence, Peyronie’s disease, urethral stricture disease, and congenital urologic abnormalities. Dr. Brady is also skilled in managing complications from prostate and pelvic cancer treatments. Read More
Mark Moyad, MD - Moderator & Extended Q&A
Dr. Mark A. Moyad, MD, MPH, is the Jenkins/Pokempner Director of Complementary and Alternative Medicine (CAM) Education at the University of Michigan Medical Center. With a career spanning more than 25 years, Dr. Moyad is dedicated to promoting comprehensive lifestyle changes to enhance mental, physical, and spiritual wellness. He is a recognized expert in clinical epidemiology and public health education, with a focus on dietary supplements and other health options. Dr. Moyad has authored over 150 medical journal articles and 15 books, and he has lectured extensively to health care professionals and the public worldwide. Read More
Mark Scholz, MD - Host & Extended Q&A
Dr. Mark C. Scholz, MD, is a double board-certified medical oncologist and the executive director of the Prostate Cancer Research Institute (PCRI). He also serves as the medical director of Prostate Oncology Specialists Inc. in Marina del Rey, CA, a practice dedicated exclusively to prostate cancer.
He is the co-author of Invasion of the Prostate Snatchers and the author of The Key to Prostate Cancer. As co-founder of PCRI, he is involved in groundbreaking research and clinical trials focused on improving prostate cancer treatment and patient outcomes. Dr. Scholz has published over 90 scholarly articles and continues to be an influential figure in the field of oncology. Read More
Ask The Experts
Przemyslaw Twardowski, MD - Hormone Treatments
Przemyslaw Twardowski is a board-certified medical oncologist, who has vast experience in the management of genitourinary malignancies including prostate, bladder, kidney and testicular cancers.
Over the last 20 years he was a principal investigator and contributor to multiple clinical trials that expanded treatment options for patients with cancers of the genitourinary tract. Dr. Twardowski is a member of the American Society of Clinical Oncology and was selected as one of America’s Top Doctors multiple times.
He has published more than 100 scientific articles, abstracts and book chapters and he lectures nationally and internationally. Read More
Tanya Dorff, MD - Clinical Trials
Tanya Barauskas Dorff, M.D., is a professor in the Department of Medical Oncology & Therapeutics Research and serves as division chief of the Genitourinary Disease Program at City of Hope. She is an internationally recognized leader in prostate cancer, and is renowned for her work in other genitourinary tumor types, including kidney, bladder and penile cancer.
Dr. Dorff has assumed control of one of the largest clinical trial portfolios in genitourinary cancers, and treats patients with all types of genitourinary cancers, including testicular and penile cancer. Read More
Henry Yampolsky, MD - Radiation Therapy
Henry Yampolsky, M.D., is one of only a few Russian-speaking radiation oncologists in the United States. He grew up in the former Soviet Union where he studied computer science at one of the most prestigious universities in Moscow. After immigrating to the United States in 1992, Dr. Yampolsky graduated from the University of California Los Angeles with a B.S. in Biochemistry. He received his M.D. degree from the University of Southern California.
While at USC, Dr. Yampolsky acquired broad clinical expertise in the treatment of cancer, as well as extensive experience with intensity modulated radiation therapy (IMRT) and stereotactic radiotherapy. Read More
Richard Lam, MD - Advanced Treatments (Chemo, Pluvicto, and More)
Dr. Lam has written numerous articles based on his research. He is an active member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Lam continues to promote prostate cancer awareness and education by giving lectures at various medical conferences and prostate support groups throughout the country. He is particularly interested in utilizing state-of-the-art therapeutics for advanced prostate cancer.
Dr. Lam received his undergraduate degree in biology, magna cum laude, at UCLA. He then went on to earn his medical degree at UCLA School of Medicine before completing his residency training in the specialty of internal medicine at UCLA Center of Health Sciences. He completed his oncology and hematology fellowship at Harbor-UCLA Medical Center. Read More
AGENDA
FRIDAY, SEPTEMBER 6, 2024
4:00pm - 7:00pm / Early Check-In Available
5:00pm - 6:30pm / PCRI Patient Welcome Receptions With Mark Scholz, MD & The PCRI Team
SATURDAY, SEPTEMBER 7, 2024
6:30am - 5:00pm / Registration Open
6:30am - 7:30am / Breakfast Session: To Be Announced
7:30am - 5:30pm / Exhibit Hall Open
8:00am - 8:30am / Opening Remarks / Mark Moyad, MD & Mark Scholz, MD
8:15am - 9:30am / General Session & Q+A: Advanced Treatments & Side Effects / Elisabeth Heath, MD
9:30am - 10:15am / Break
10:15am - 11:15am / General Session & Q+A: Active Surveillance / Laurence Klotz, MD
11:15am - 1:30pm / Lunch Break
12:15pm - 1:15pm / Support Groups
Low Risk (Active Surveillance) Support Group
Intermediate Risk Support Group
High Risk Support Group
Recurrence Support Group
Advanced Support Group
1:30pm - 2:20pm / General Session & Q+A: Radiation & Side Effects / Mack Roach III, MD
2:20pm - 3:10pm / General Session & Q+A: Prostate Imaging / Daniel Margolis, MD
3:10pm - 3:30pm / Break
3:30pm - 4:30pm / General Session & Q+A: Sexual Side Effects / Jeffrey Brady, MD
7:00pm - 9:00pm / Patient Meet & Greet Party | Details To Be Announced
SUNDAY, SEPTEMBER 8, 2024
6:30am - 7:30am / Sponsored Breakfast / Details Coming Soon
7:30am - 10:30pm / Registration Open / Registration Desk
7:30am - 12:00pm / Exhibit Hall Open /
8:00am - 9:45am / Ask the Experts Q&A | Get Your Questions Answered
Sexual Side Effects + Urinary Incontinence / To Be Announced
PET CT Prostate Imaging & Prostate MRI / Daniel Margolis, MD
Hormone Treatments / Przemyslaw Twardowski, MD
Clinical Trials / Tanya Dorff, MD
Radiation Therapy / Henry Yampolsky, MD
Advanced Treatments (Chemo, Pluvicto, and More) / Richard Lam, MD
Active Surveillance / Laurence Klotz, MD
Diet & Nutrition / To Be Announced
9:45am - 10:ooam / Break
10:00am - 12:00pm / General Session: Conference Review / Mark Moyad, MD, MPH & Mark Scholz, MD
*Agenda subject to change